← All trials
NCT04676776
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2021
- Primary completion
- Dec 31, 2021
- Completion date
- Dec 31, 2021
- First posted
- Dec 21, 2020
- Last posted
- Dec 23, 2020
- Enrollment
- 139
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Gynuity Health ProjectsLead sponsor
- Gynuity Health ProjectsOverall official - principal investigator
- Gynuity Health ProjectsStudy director
- Cuidado Integral de la Mujer, Gineclinic, S.C.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.